Clin2
NCT07635394Possibly a fitRecruiting

Pregabalin for Irritable Bowel Syndrome Relief

Irritable Bowel Syndrome (IBS)

Part of Digestive system clinical trials.

This study tests whether pregabalin, a nerve-pain medication, can help reduce irritable bowel syndrome (IBS) symptoms like abdominal pain and irregular bowel habits. Researchers want to see if it's safe and effective for people with mild-to-moderate IBS.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
258 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Age 18–70 years old
  • Diagnosed with IBS using Rome IV criteria (a standard diagnostic test)
  • Mild-to-moderate IBS symptoms, not severe
  • Not pregnant, breastfeeding, or planning pregnancy during the study
  • No severe mental health conditions or recent self-harm thoughts
  • Haven't taken pregabalin in the past 30 days and no allergy to it

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07584278Recruiting
Probiotics and Biomarkers for Irritable Bowel Syndrome

This study tests whether probiotics (beneficial bacteria) can help reduce irritable bowel syndrome (IBS) symptoms and change certain markers in your gut. You'll take a probiotic supplement for 12 weeks while researchers track how your symptoms and gut health change.

Gothenburg
NCT07475299Not yet recruiting
Synbiotic supplement for IBS symptoms

This study tests a special supplement (a synbiotic with plant extracts) to see if it helps balance gut bacteria and improve IBS symptoms like bloating, belly pain, and irregular bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca
NCT07125625Not yet recruiting
Probiotic mix for children with irritable bowel syndrome

This trial tests if a mix of two probiotics (L. Rhamnosus GG and L. Plantarum 299V) can help reduce belly pain in children ages 4 to 18 who have irritable bowel syndrome (IBS). If your child has daily belly pain and has been diagnosed with IBS, this treatment might offer relief.

Bari, Bari
NCT06681012Recruiting
Gelsectan for irritable bowel syndrome with diarrhea

This trial tests a supplement called Gelsectan to see if it reduces diarrhea and belly pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may help if you have loose, urgent stools more often than not.

Leuven
NCT06668922Recruiting
Diet and irritable bowel syndrome study

This study compares how people with and without irritable bowel syndrome (IBS) react to different foods. It may help find which foods trigger symptoms and which are safe to eat.

Los Angeles, California
NCT06090110Recruiting
Vagus nerve stimulation for irritable bowel syndrome

This study tests whether a gentle electrical device that stimulates the vagus nerve can help relieve symptoms of irritable bowel syndrome. If you have IBS and are between 18 and 75, you may be able to join.

Maastricht, Limburg

Hear when a new Irritable Bowel Syndrome (IBS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.